The Daily Aus (TDA) has launched a new original podcast series examining the complex world of medicated weight loss.
Investigating Ozempic, hosted and produced by TDA’s Features Editor Emma Gillespie, dives deep into Australia’s medical weight-loss industry, offering unprecedented insight into how young people are engaging with high-profile medications like Ozempic, Wegovy and Mounjaro.
Over three episodes, the podcast explores the complex medical, ethical, and commercial landscape behind the global rise of these drugs with in-depth interviews, firsthand accounts, and commentary from health professionals.
The series also raises questions about patient care, safety protocols, and marketing and prescribing practices in a rapidly evolving health sector.
A survey of more than 23,000 TDA followers found 11% of young people have used Ozempic or a similar drug, while 43% of respondents said they want to (or have previously wanted to) try weight-loss medication.
“Ozempic has dominated headlines over recent years, but the experience of young Australians has been missing from the conversation,” Investigating Ozempic host Gillespie said.
“We received overwhelming feedback from our audience, including hundreds of lived-experience anecdotes, warranting further scrutiny into how these medications are being prescribed, monitored and marketed to young people. This series aims to provide clarity and context to an issue that touches many aspects of young people’s lives.”
The first episode of Investigating Ozempic is available now on Spotify and other streaming platforms, with parts two and three dropping on 20 and 21 May, respectively.
The Investigating Ozempic podcast launch by The Daily Aus comes after the recent launch of TDA Finance, a new weekly newsletter that aims to empower young Australians with the financial literacy they need to make sense of the world.